Chemclin Diagnostics Co., Ltd. (SHA:688468)
China · Delayed Price · Currency is CNY 6.16
-0.01 (-0.16%)
Aug 4, 2026, 3:00 PM CST
Chemclin Diagnostics Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 324.73 | 332.68 | 436.29 | 445.34 | 465.27 | 470.77 |
Revenue Growth | -20.06% | -23.75% | -2.03% | -4.28% | -1.17% | 12.57% |
Gross Profit Gross Profit Growth | 204.31 | 213.58 | 320.94 | 334.78 | 344.16 | 350.94 |
Operating Income Operating Income Growth | 26.2 | 31.14 | 107.65 | 131.61 | 135.11 | 137.12 |
Net Income Net Income Growth | 38.33 | 43.91 | 127.07 | 147.37 | 152.63 | 142.76 |
Earnings Per Share EPS Growth | 0.09 | 0.11 | 0.32 | 0.37 | 0.38 | 0.37 |
EPS Growth | -65.37% | -65.63% | -13.51% | -2.63% | 2.70% | 12.12% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 388.7 | 615.11 | 909.25 | 918.66 | 985.14 | 924.63 |
Total Debt Total Debt Growth | 232.62 | 231.97 | 249.76 | 234.61 | 12.47 | 24.6 |
Net Cash (Debt) Net Cash Growth | 156.08 | 383.14 | 659.5 | 684.05 | 972.67 | 900.03 |
Net Cash Growth | -75.14% | -41.90% | -3.59% | -29.67% | 8.07% | 62.64% |
Net Cash Per Share Net Cash Per Share Growth | 0.37 | 0.96 | 1.66 | 1.72 | 2.42 | 2.33 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 103.13 | 93.9 | 167.95 | 173.05 | 244.56 | 188.86 |
Capital Expenditures CapEx Growth | -41.12 | -69.88 | -107.49 | -301.37 | -125.28 | -72.55 |
Free Cash Flow Free Cash Flow Growth | 62.01 | 24.01 | 60.46 | -128.32 | 119.28 | 116.31 |
Free Cash Flow Growth | 2.96% | -60.28% | - | - | 2.55% | 69.43% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 62.92% | 64.20% | 73.56% | 75.17% | 73.97% | 74.54% |
Operating Margin | 8.07% | 9.36% | 24.67% | 29.55% | 29.04% | 29.13% |
Pretax Margin | 14.10% | 14.97% | 31.61% | 37.30% | 38.12% | 34.45% |
Profit Margin | 11.80% | 13.20% | 29.13% | 33.09% | 32.80% | 30.32% |
FCF Margin | 19.10% | 7.22% | 13.86% | -28.81% | 25.64% | 24.71% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.125 | - | 0.125 | 0.125 | 0.347 | 0.170 |
Dividend Per Share Growth | 0% | - | 0% | -63.98% | 104.12% | - |
Dividend Yield | 2.03% | - | 1.86% | 1.20% | 3.91% | 1.03% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 67.55 | 65.96 | 21.27 | 29.36 | 24.88 | 50.34 |
P/FCF Ratio | 39.20 | 120.62 | 44.71 | - | 31.84 | 61.78 |
PS Ratio | 7.49 | 8.71 | 6.20 | 9.72 | 8.16 | 15.26 |